Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
calcium antagonist
CAT scan
CAT scan, abnormal
CAT scan, early changes in CVA
cerebral embolism
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, pathophysiology
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, young adult
efficacy
embolism
fibrinolytic agents
fibrinolytic therapy, timing of administration
intracerebral hemorrhage
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, diffusion weighted
MRI, early changes in CVA
neuroprotective agents
NMDA antagonists
prognosis
protocol violations
research
review article
risk factors
safety
tissue plasminogen activator antigen
tissue plasminogen activator, intravenous
treatment of neurologic disorder
Showing articles 750 to 800 of 1427 << Previous Next >>

Cerebrovascular Events After Myocardial Infarction:Analysis of the GISSI Trial
BMJ 302:1428-1431, Maggioni,A.P.,et al, 1991

Guillain-Barre Syndrome After Streptokinase Therapy
Acta Neurologica Scand 82:153, Roquer,J.,et al, 1990

Ancrod Causes Rapid Thrombolysis in Patients with Acute Stroke
Am J Med Sci 299:319-325, Polla,K.V.E.,et al, 1990

Reptured Arteriovenous Malformation Complicating Thrombolytic Therapy with Tissue Plasminogen Activator
Arch Neurol 47:105-106, Proner,J.,et al, 1990

Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990

Multiple Microembolic after Disintegration of Clot During Thrombolysis for Acute Myocardial Infarction
BMJ 299:1310-1312, Stafford,P.J.,et al, 1989

Genetic Factors in Myasthenia Gravis:A Family Study
Neurol 38:38-42, Kerzin-Storrar,L.,et al, 1988

Thrombolytic Therapy in Cerebrovascular Disease
Stroke 19:1174-1179, DelZoppo,G.J., 1988

Intra-arterial Thrombolytic Therapy Improves Outcome in Patients with Acute Vertebrobasilar Occlusive Disease
Stroke 19:1216-1222, Hacke,W.,et al, 1988

Fatal Ischaemic Brain Oedema after Early Thrombolysis with Tissue Plasminogen Activator in Acute Stroke
BMJ 297:1571-1574, Koudstaal,P.J.,et al, 1988

Intracerebral Hemorrhage Complicating Intravenous Tissue Plasminogen Activator Treatment
Arch Neurol 45:1070-1073, Carlson,S.E.,et al, 1988

Local Intra-Arterial Fibrinolytic Therapy in Acute Carotid Territory Stroke, A Pilot Study
Stroke 19:307-313, delZoppo,G.J.,et al, 1988

Thrombolytic Therapy:Current Status (Second of Two Parts)
NEJM 318:1585-1595, Marder,V.J.&Sherry,S., 1988

Intracarotid Urokinase with Thromboembolic Occlusion of the Middle Cerebral Artery
Stroke 19:802-812, Mori,E.,et al, 1988

Use of Ancrod in Acute or Progressing Ischemic Cerebral Infarction
Ann Emerg Med 17:1208-1209, Olinger,C.P.,et al, 1988

Thrombolysis & Stroke, Past & Future
Arch Neurol 44:748-768, Sloan,M.A., 1987

Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987

Cerebrovascular Complications of Streptokinase Infusion
JAMA 253:1777-1779, Aldrich,M.S.,et al, 1985

Controlled Trial of Ancrod in Ischemic Stroke
Arch Neurol 40:803-808, Hossman,V.,et al, 1983

HLA-B8 in Polymyositis
NEJM 298:1260, Behan,W.M.H.,et al, 1978

HLA Antigens in the Landry-Guillain-Barre Syndrome & Chronic Relapsing Polyneuritis
Ann Neurol 4:285-289, Stewart,G.J.,et al, 1978

Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976

Cogan's Syndrome & HLA BW17
NEJM 295:1262, DelCarpio,J.,et al, 1976

MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,

A 35-Year-Old Man with Recurrent Asymmetric Lumbosacral and Cervical Plexopathy
Neurol 106:e214910, Tayade,K.S., et al, 2026

Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026

Inflammatory Myopathies
NEJM 394:1925-1938, AllenBach,Y. & Benveniste,O., 2026

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia
Neurol 106:e214933, van Steenhoven,R.W.,et al, 2026

Creutzfeldt-Jakob-Like Presentation in Anti-AMPAR Encephalitis
Ann Neurol 99:1466-1467, Durbano,K.et al, 2026

Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026

Anti-NMDAR Encephalitis Triggered by EBV and HSV-1
Medicine 104:28, Zhan,X.,et al, 2025

Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025

A 56-Year-Old Woman with Right-Sided Weakness and Recurrent MRI Lesions
Neurol 105:e214293, Vorobyev,A.,et al, 2025

Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025

Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis:A Systematic Review and Meta-Analysis
AJNR 45:977-986, Almeida,F.C.,et al, 2024

Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
NEJM 391:1256-1258, Laugwitz,L.,et al, 2024

Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024

Magnetic Resonance Imaging Characteristics of LGl1-Antibody and CASPR2-Antibody Encephalitis
JAMA Neurol 81:525-533, Kelly,Mark J., et al, 2024

Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024

Overlapping Anti-NMDAR Encephalitis and Multiple Sclerosis: A Case Report and Literature Review
Front Immunol doi:10.3389/Fimmun.2023.1088801, Liu,P.,et al, 2023

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Clinical Features and Diagnosis
UptoDate.com, March, Flanagan,E.P. & Tillema,J-M, 2023

Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023

Posterior Reversible Encephalopathy Syndrome
NEJM 388:2171-2178, Geocadin,R.G., 2023

Glucose Hypermetabolism in the Basal Ganglia
Neurol 101:90-91, Kim,Y.E.,et al, 2023

Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease:International MOGAD Panel Proposed Criteria
Lancet Neurol doi.org110.1016/51474-4422(22)00431-8, Banwell,B.,et al, 2023

Anti0NMDAR Encephalitis Presenting with Unilateral Insular Diffusion Restriction on Brain Imaging: Mimicking as a Stroke
Ann Clin Case Rep 8:21515, Pawar,M.,et al, 2023

Recurrent Anti-NMDA Receptor Encephalitis After Mycoplasma Pnemonia Infection
Am J Psychiatry 180:880-883, Dickson,K.S.,et al, 2023

Autoimmune Nodopathies, An Emerging Dignostic Category
Curr Opin Neurol 35:579-585, Martin-Agullar, L.,et al, 2022



Showing articles 750 to 800 of 1427 << Previous Next >>